β1 receptors protect the renal afferent arteriole of angiotensin-infused rabbits from norepinephrine-induced oxidative stress

Journal of the American Society of Nephrology

Volumn 17, Issue 12, 2006, Pages 3347-3354

  Wang, Dan ^a   Jose, Pedro ^b   Wilcox, Christopher S ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP DERIVATIVE; DOBUTAMINE; ETHIDIUM; HYDROETHIDINE; NORADRENALIN; PHENYLEPHRINE; PROPRANOLOL; SALBUTAMOL; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; BETA ADRENERGIC STIMULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; KIDNEY AFFERENT ARTERIOLE; KIDNEY ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; RENAL PROTECTION;

EID: 33845273341     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006030212     Document Type: Article

References (47)

1. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997
2. Wilcox CS: Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-R935, 2005
3. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996
4. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS: A mouse model of angiotensin II slow pressor response: Role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002
5. Ortiz MC, Sanabria E, Manriquez MC, Romero JC, Juncos LA: Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension 37: 505-510, 2001
6. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS: Angiotensin-induced defects in renal oxygenation: Role of oxidative stress. Am J Physiol Heart Circ Physiol 288: H22-H28, 2005
7. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, Wilcox CS: Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 14: 2783-2789, 2003
8. Ames RP, Borkowski AJ, Sicinski AM, Laragh JH: Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, and aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest 44: 1171-1186, 1965
9. Atkinson AB, Brown JJ, Fraser R, Lever AF, Morton JJ, Riegger AJ, Robertson JI: Angiotensin II and renal hypertension in dog, rat and man: Effect of converting enzyme inhibition. Clin Exp Hypertens 2: 499-524, 1980
10. Csiky B, Simon G: Synergistic vascular effects of dietary sodium supplementation and angiotensin II administration. Am J Physiol 273: H1275-H1282, 1997
11. Wang D, Chabrashvili T, Wilcox CS: Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res 94: 1436-1442, 2004
12. Welch WJ, Ahlstrom NG, Wilcox CS: Mechanism of hypertension during prolonged infusion of thromboxane mimetic. Eur J Int Med 2: 277-280, 1992
13. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, Granger JP: Role of reactive oxygen species in endothelin-induced hypertension. Hypertension 42: 806-810, 2003
14. Wang D, Borrego-Conde LJ, Falck JR, Sharma KK, Wilcox CS, Umans JG: Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles. Kidney Int 63: 2187-2193, 2003
15. Schnackenberg CG, Wilcox CS: The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59: 1859-1864, 2001
16. Randall MD, McCulloch AI: The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br J Pharmacol 115: 607-612, 1995
17. Briones AM, Daly CJ, Jimenez-Altayo F, Martinez-Revelles S, Gonzalez JM, McGrath JC, Vila E: Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries. Br J Pharmacol 146: 679-691, 2005
18. Juncos LA, Ito S, Carretero OA, Garvin JL: Removal of endothelium-dependent relaxation by antibody and complement in afferent arterioles. Hypertension 23: 154-159, 1994
19. Schnackenberg CG, Welch WJ, Wilcox CS: TP receptor-mediated vasoconstriction in microperfused afferent arterioles: Roles of O(2)(-) and NO. Am J Physiol Renal Physiol 279: F302-F308, 2000
20. Takagawa Y, Berger ME, Tuck ML, Golub MS: Impaired endothelial alpha-2 adrenergic receptor-mediated vascular relaxation in the fructose-fed rat. Hypertens Res 25: 197-202, 2002
21. Zhang X, Hintze TH: cAMP signal transduction cascade, a novel pathway for the regulation of endothelial nitric oxide production in coronary blood vessels. Arteriosder Thromb Vasc Biol 21: 797-803, 2001
22. White R, Bottrill FE, Siau D, Hiley CR: Protein kinase A-dependent and -independent effects of isoproterenol in rat isolated mesenteric artery: Interactions with levcromakalim. J Pharmacol Exp Ther 298: 917-924, 2001
23. Pourageaud F, Leblais V, Bellance N, Marthan R, Muller B: Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 372: 14-23, 2005
24. Fiordaliso F, Cuccovillo I, Blanchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S: Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci 79: 121-129, 2006
25. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB: Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 29: 2571-2583, 1997
26. Mori T, Cowley AW Jr: Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 42: 588-593, 2003
27. Zhang Z, Rhinehart K, Kwon W, Weinman E, Pallone TL: Ang II signaling in vasa recta pericytes by PKC and reactive oxygen species. Am J Physiol Heart Circ Physiol 287: H773-H781, 2004
28. Salomonsson M, Arendshorst WJ: Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration. Am J Physiol 276: F700-F710, 1999
29. Facemire CS, Arendshorst WJ: Calmodulin mediates norepinephrine-induced receptor-operated calcium entry in preglomerular resistance arteries. Am J Physiol Renal Physiol 289: F127-F136, 2005
30. Nishio E, Watanabe Y: The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol 121: 665-670, 1997
31. Bleeke T, Zhang H, Madamanchi N, Patterson C, Faber JE: Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45, 2004
32. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597-598, 1967
33. Skeberdis VA: Structure and function of beta3-adrenergic receptors. Medicina (Kaunas) 40: 407-413, 2004
34. Kopp UC, DiBona GF: Interaction between neural and nonneural mechanisms controlling renin secretion rate. Am J Physiol 246: F620-F626, 1984
35. Buhler FR, Burkart F, Lutold BE, Kung M, Marbet G, Pfisterer M: Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol 36: 653-669, 1975
36. Chruscinski A, Brede ME, Meinel L, Lohse MJ, Kobilka BK, Hein L: Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors. Mol Pharmacol 60: 955-962, 2001
37. Boivin V, Jahns R, Gambaryan S, Ness W, Boege F, Lohse MJ: Immunofluorescent imaging of beta1- and beta2-adrenergic receptors in rat kidney. Kidney Int 59: 515-531, 2001
38. Taira N, Yabuuchi Y, Yamashita S: Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs. Br J Pharmacol 59: 577-583, 1977
39. Wellstein A, Belz GG, Palm D: Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots. J Pharmacol Exp Ther 246: 328-337, 1988
40. Hajj-Ali AF, Wong PC: Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan. J Pharmacol Exp Ther 267: 1423-1427, 1993
41. Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J: Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation 101: 2302-2308, 2000
42. Lu Q, Asico LD, Jones JE, Bai R, Li H, Maines MD, Jose PA: Impaired heme oxygenase activity, increased reactive oxygen species, and high blood pressure in D5 dopamine receptor deficient mice [Abstract]. J Am Soc Nephrol 16: 163A, 2005
43. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA: D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R96-R104, 2006
44. Mason RP, Walter MF, Trumbore MW, Olmstead EG Jr, Mason PE: Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol 31: 275-281, 1999
45. Schiffrin EL, Pu Q, Park JB: Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens 15: 105-110, 2002
46. Lindholm LH, Carlberg B, Samuelsson O: Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 366: 1545-1553, 2005
47. Carlberg B, Samuelsson O, Lindholm LH: Atenolol in hypertension: Is it a wise choice? Lancet 364: 1684-1689, 2004